A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance

NCT06313255 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-05-01

No results posted yet for this study

Summary

The goal of this retrospective observational study is to find out the effects of probiotics on HBV clearance. The main question it aims to answer is:

Are the probiotics have an effect in promoting HBV clearance? The participants will observe the HBV clearance rate in chronic hepatitis B patients receive probiotics in addition to the routine antiviral therapy.

Researchers will compare the HBV clearance rate in chronic hepatitis B patients receive probiotics and antiviral therapy with those receiving solely antiviral therapy.

Conditions

Interventions

DRUG

PegIFNα2b

The patients receive PegIFNα2b therapy

DRUG

PegIFNα2b+probiotics

The patients receive both PegIFNα2b and probiotics therapy

DRUG

Nucleoside analog

The patients receive nucleoside analog therapy

DRUG

Nucleoside analog+probiotics

The patients receive both nucleoside analog and probiotics therapy

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06313255 on ClinicalTrials.gov